Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.45B |
| 2 |
Visa
V
|
+$1.05B |
| 3 |
Microsoft
MSFT
|
+$1.01B |
| 4 |
Apple
AAPL
|
+$578M |
| 5 |
Norfolk Southern
NSC
|
+$545M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$1.24B |
| 2 |
McDonald's
MCD
|
+$707M |
| 3 |
JPMorgan Chase
JPM
|
+$680M |
| 4 |
Texas Instruments
TXN
|
+$678M |
| 5 |
Edwards Lifesciences
EW
|
+$664M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.8% |
| 2 | Healthcare | 2.66% |
| 3 | Financials | 2.38% |
| 4 | Consumer Discretionary | 2.05% |
| 5 | Industrials | 2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BZAI
11926
Blaize Holdings
BZAI
$85.9M
| $80.8K | ﹤0.01% |
23,427
+9,118
| +64% | +$32.4K |
|
11927
PUT
Gerdau
GGB
$9.3B
| $80.6K | ﹤0.01% |
26,000
+11,800
| +83% | +$35.7K |
|
11928
CALL
Lantern Pharma
LTRN
$33.9M
| $80K | ﹤0.01% |
18,400
+2,000
| +12% | +$8.35K |
|
|
NEWP
11929
CALL
New Pacific Metals
NEWP
$1.27B
| $79.9K | ﹤0.01% |
+29,500
| New | +$54.8K |
|
11930
CALL
Nuvation Bio
NUVB
$2.18B
| $79.9K | ﹤0.01% |
21,600
-40,400
| -65% | -$110K |
|
|
OMSE
11931
OMS Energy Technologies
OMSE
$191M
| $79.9K | ﹤0.01% |
+18,804
| New | +$119K |
|
11932
PUT
Annovis Bio
ANVS
$78.7M
| $79.9K | ﹤0.01% |
38,600
+4,700
| +14% | +$11.7K |
|
|
ADAG
11933
Adagene
ADAG
$244M
| $79.8K | ﹤0.01% |
+40,516
| New | +$82.9K |
|
11934
PUT
Hain Celestial
HAIN
$52.4M
| $79.8K | ﹤0.01% |
50,500
+1,500
| +3% | +$2.56K |
|
11935
CALL
Alto Ingredients
ALTO
$324M
| $79.7K | ﹤0.01% |
73,800
-3,300
| -4% | -$3.71K |
|
11936
PUT
Neumora Therapeutics
NMRA
$301M
| $79.5K | ﹤0.01% |
43,700
-10,800
| -20% | -$17.5K |
|
11937
Quest Resource Holding
QRHC
$33.7M
| $79K | ﹤0.01% |
50,626
-3,912
| -7% | -$7.25K |
|
11938
Toro Corp
TORO
$195M
| $79K | ﹤0.01% |
+25,388
| New | +$72.6K |
|
11939
Mobile Infrastructure Corp
BEEP
$107M
| $78.8K | ﹤0.01% |
+22,374
| New | +$84.9K |
|
11940
Lesaka Technologies
LSAK
$407M
| $78.8K | ﹤0.01% |
18,977
+3,959
| +26% | +$17.9K |
|
11941
Cardio Diagnostics
CDIO
$6.04M
| $78.7K | ﹤0.01% |
+19,520
| New | +$77.1K |
|
11942
Data Storage Corp
DTST
$7.15M
| $78.6K | ﹤0.01% |
18,199
-15,184
| -45% | -$67.6K |
|
11943
PUT
ADC Therapeutics
ADCT
$129M
| $78.4K | ﹤0.01% |
19,600
+800
| +4% | +$2.52K |
|
11944
Nephros
NEPH
$50.3M
| $78.3K | ﹤0.01% |
16,545
+4,655
| +39% | +$18.3K |
|
|
ADVM
11945
DELISTED
Adverum Biotechnologies
ADVM
| $78.2K | ﹤0.01% |
17,267
-61,004
| -78% | -$180K |
|
|
ADAM
11946
Adamas Trust
ADAM
$910M
| $78.1K | ﹤0.01% |
+11,212
| New | +$77.9K |
|
11947
CALL
Sportsman's Warehouse
SPWH
$46.4M
| $77.8K | ﹤0.01% |
28,100
-2,100
| -7% | -$6.7K |
|
11948
PUT
Relay Therapeutics
RLAY
$4.35B
| $77.8K | ﹤0.01% |
14,900
-21,200
| -59% | -$80.8K |
|
11949
EUDA Health Holdings
EUDA
$42.4M
| $77.7K | ﹤0.01% |
2,232
+816
| +58% | +$39.6K |
|
11950
China SXT Pharmaceuticals
SXTC
$2.31M
| $77.5K | ﹤0.01% |
+4
| New | +$79K |
|
Similar funds
Ken Griffin's Q3 2025 Portfolio in Review
As of Q3 2025, Ken Griffin held 14,587 positions worth $657B, up 14% from $576B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ken Griffin's Q3 2025 filing shows 2,292 new, 5,364 increased, 4,887 reduced and 1,963 closed positions. Its largest new stake was Permian Resources: 18,381,735 shares worth $235M. The largest sale was Hess, an estimated $1.24B.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3.3% a quarter earlier, followed by Healthcare and Financials.
- Ken Griffin's largest Q3 2025 buy was Permian Resources: 18,381,735 shares worth $235M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q3 2025, an estimated $1.45B increase.
- Ken Griffin's biggest Q3 2025 reduction was McDonald's, cutting an estimated $707M.
- Ken Griffin fully exited Hess in Q3 2025, selling an estimated $1.24B.
- Ken Griffin's ten largest holdings make up 25% of its $657B portfolio in Q3 2025.
- Ken Griffin opened 2,292 new positions and closed 1,963 in Q3 2025.
- Ken Griffin's portfolio value rose 14% quarter-over-quarter to $657B.
Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.